BGI GenoImmune
华大吉诺因
BGI GenoImmune
Biotech/Healthcare
BGI Genomics is a high-tech biotechnology company focused on tumor immunotherapy. By leveraging advanced life digitization technologies, the company seeks to fully activate the human immune system against cancer and develop novel preventive and therapeutic solutions targeting tumor-specific…
Latest round: Strategic (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.